These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3258464)

  • 1. Inhibition by cartilage and bone marrow fractions of cartilage resorption induced by interleukin-1 and tumour necrosis factor.
    Rainsford KD
    Agents Actions; 1988 Feb; 23(1-2):67-8. PubMed ID: 3258464
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee.
    Bolon B; Campagnuolo G; Zhu L; Duryea D; Zack D; Feige U
    Vet Pathol; 2004 May; 41(3):235-43. PubMed ID: 15133172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
    Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
    Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage proteoglycan release assay.
    Billington CJ
    Methods Mol Biol; 2001; 151():451-6. PubMed ID: 11217320
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulation of cartilage resorption by extracellular ATP acting at P2-purinoceptors.
    Leong WS; Russell RG; Caswell AM
    Biochim Biophys Acta; 1994 Nov; 1201(2):298-304. PubMed ID: 7947945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines and focal loss of cartilage in osteoarthritis.
    Elson CJ; Mortuza FY; Perry MJ; Warnock MG; Webb GR; Westacott CI
    Br J Rheumatol; 1998 Jan; 37(1):106-7. PubMed ID: 9487263
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological influence of antirheumatic drugs on proteoglycans from interleukin-1 treated articular cartilage.
    Steinmeyer J; Daufeldt S
    Biochem Pharmacol; 1997 Jun; 53(11):1627-35. PubMed ID: 9264315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1: purification and biochemical aspects of its action on cartilage.
    Saklatvala J
    J Rheumatol; 1987 May; 14 Spec No():52-4. PubMed ID: 3498042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anti-inflammatory drugs on interleukin 1-induced cartilage proteoglycan resorption in-vitro: inhibition by aurothiophosphines but no influence from perturbed eicosanoid metabolism.
    Rainsford KD
    J Pharm Pharmacol; 1989 Feb; 41(2):112-7. PubMed ID: 2568418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antirheumatic drugs on the interleukin-1 alpha induced synthesis and activation of proteinases in articular cartilage explants in culture.
    Arsenis C; McDonnell J
    Agents Actions; 1989 Jun; 27(3-4):261-4. PubMed ID: 2678951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interleukin-1-beta and tumor necrosis factor-alpha on cartilage proteoglycan metabolism in vitro.
    Pratta MA; Di Meo TM; Ruhl DM; Arner EC
    Agents Actions; 1989 Jun; 27(3-4):250-3. PubMed ID: 2801305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
    Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
    J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid and interleukin-1 together promote the release of collagen fragments from bovine nasal cartilage in culture.
    Cawston TE; Ellis AJ
    Ann N Y Acad Sci; 1996 Jun; 785():219-23. PubMed ID: 8702134
    [No Abstract]   [Full Text] [Related]  

  • 14. Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases.
    Morgan TG; Rowan AD; Dickinson SC; Jones D; Hollander AP; Deehan D; Cawston TE
    Ann Rheum Dis; 2006 Feb; 65(2):184-90. PubMed ID: 15975972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar regulation of chondrocyte functions by cellular stimulants of unknown mechanism. Retinoids, cytokines, and bacterial lipopolysaccharide.
    Benton HP
    Biochem Pharmacol; 1990 Jan; 39(1):1-6. PubMed ID: 2404492
    [No Abstract]   [Full Text] [Related]  

  • 16. Aminothiazole derivatives with antidegenerative activity on cartilage.
    Panico AM; Geronikaki A; Mgonzo R; Cardile V; Gentile B; Doytchinova I
    Bioorg Med Chem; 2003 Jul; 11(13):2983-9. PubMed ID: 12788367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical investigations of the cartilage extract in Rumalon.
    Kalbhen DA
    Med Pharmacol Exp Int J Exp Med; 1966; 15(4):344-50. PubMed ID: 4225246
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence that the inhibition of cartilage proteoglycan breakdown by mannosamine is not mediated via inhibition of glycosylphosphatidylinositol anchor formation.
    Bryson H; Buttle DJ; Kozaci LD; Johnatty RN; Bunning RA
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):495-501. PubMed ID: 10642507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cartilage proteoglycan synthesis by interleukin I.
    Benton HP; Tyler JA
    Biochem Biophys Res Commun; 1988 Jul; 154(1):421-8. PubMed ID: 3260778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interleukin-1 and tumour necrosis factor-alpha on the turnover of proteoglycans in human articular cartilage.
    Hickery MS; Vilim V; Bayliss MT; Hardingham TE
    Biochem Soc Trans; 1990 Oct; 18(5):953-4. PubMed ID: 2083761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.